Local Anogenital Service
mASCARA team setting up a local anogenital service. Anogenital HSIL is best managed in a multidisciplinary setting involving the sexual health, dermatology, obstetrics and gynaecology and colorectal teams. We are in the process of building a service targeting the early … Continued
The Lost Tribe
An excellent read for the Christmas break. Here is a summary of the Review published by the mASCARA team: Anal cancer rates are on the rise, especially for women. Women with a background of genital dysplasia or cancer have been … Continued
ESCP 21-23 September 2022
mASCARA team at ESCP in Dublin, presenting our local data on the management of anal HSIL in women. Our audit highlighted that out of 91 women with anal cancer (between 2001 and 2022) only 1 was being monitored for anal … Continued
ACPGBI Edinburgh
The mASCARA team attended ACPGBI in Edinburgh. Miss Sarah Mills presented at the Anal Cancer Symposium. There is an ongoing need to improve research focused around the early detection and prevention of anal cancer. The importance of an International Anal … Continued
International Anal Neoplasia Society Meeting New York
Sarah and Danni both attended the IANS meeting in New York in June 2022. As well as enjoying the New York city life, we presented the study teams work on the treatment of early ASCC.
The Anchor Study
The results from the ANCHOR study have been published. This is the first randomised control trial to finally determine the benefit of treating anal HSIL in the prevention of anal squamous cell carcinoma in PLWH. The study showed a 57% … Continued
International Anal Neoplasia Society Scientific Meeting Amsterdam 2019
Danni and Sarah from the mASCARA team are attending the IANS Scientific Meeting in Amsterdam in November. The programme looks excellent, in particular we are looking forward to the updates on the SPANC and ANCHOR trials. We are also looking forward to … Continued
mASCARA team in Vienna
Members of the mASCARA team are attending the European Society of Coloproctology Conference later this month in Vienna where we will be presenting our work on Anal Intraepithelial Neoplasia topical and ablative treatments. We are looking to make further collaborations … Continued